Featured Cassava Sciences, Inc. (SAVA) stock is jumping high on 7.26% – Recent News Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed
Featured Cassava Sciences Stock Soared 130% on Monday Followed by Positive Results of New Alzheimer’s Phase 2 Trials The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a